SION compared with ARTV: revenue, margins and what each company keeps, and the suppliers and customers both name

SIONSionna Therapeutics, Inc.

Mkt capRevenueRevenue

ARTVArtiva Biotherapeutics, Inc.

Mkt capRevenueRevenue

Compare

SIONSionna Therapeutics, Inc.

ARTVArtiva Biotherapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

SION

1 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26—▲+4.80%—

May 12 '26±10.9%▼−10.90%×1.00

Q1 FY26—▼−7.17%—

Nov 5 '25—▼−1.57%—

ARTV2 of 4 reports

0 of 2at or beyond implied

Reportimpliedrealized× implied

Oct 27 '26±76.2%▼−30.68%×0.40

Q2 FY26±35.1%▼−2.68%×0.08

= impliedSION realized, solidARTV realized, hatchedOne scale, both sides: full bar = 77%× = |realized| ÷ impliedspan: SION 274d · ARTV 81dSource: market data

SIONSionna Therapeutics, Inc.

3.88▼−3.09%· post 3.88

Mkt cap$174.7MRevenue—

ARTVArtiva Biotherapeutics, Inc.

4.19▼−0.98%· post 4.19

ClosedOct 30 '26

Mkt cap$204.8MRevenue$251,000Q1 FY24

Compare

ClosedOct 30 '26

SIONSionna Therapeutics, Inc.

ARTVArtiva Biotherapeutics, Inc.

3.88▼−3.09%post 3.88

Price

4.19▼−0.98%post 4.19

$174.7M

Mkt cap

$204.8M

—

Revenue

$251,000Q1 FY24

SION3.88▼−3.09%vsARTV4.19▼−0.98%ClosedOct 30 '26